Support for Legal & Financial issues (Horizon Europe)
Not sure how to deal with a cost category? Questions on the project implementation? We'll clarify the situation for you.

Grant Management

In the Online Manual extensive details can be found regarding the application process as well as the Grant Management, thus in-depth explanations about reporting, amendments, deliverables, dissemination&exploitation, etc. The manual is expected to be complemented throughout the programming period.

All available reference documents of Horizon Europe can be found on the Funding and Tender Portal.

 

Your NCP contacts for this programme

Image of Ann Van Hauwaert

Ann Van Hauwaert

ann.vanhauwaert@fwo.be

+32 2 550 15 60

Image of Ria De Breucker

Ria De Breucker

Ria.debreucker@vlaio.be

+32 2 553 13 77

Your PC contact for this programme

Find the contact info on the site of WEWIS

The National Contact Points (NCPs) provide support, guidance, and practical information to potential applicants, helping them navigate funding opportunities and application processes.

The Programme Committee (PC) members represent their country in decision-making about the work programmes, evaluate implementation, and provide strategic input on priorities and calls.

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.